Showing results (151-160 of 172) with videos related to
Sort By:
Pageof 18
Endocrinology|May 22, 2002
Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonistsDavid L Gerhold, Franklin Liu, Guoqiang Jiang, et al.Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Aryloxazolidinediones: identification of potent orally active PPAR dual alpha/gamma agonistsRanjit C Desai, Dominick F Gratale, Wei Han, et al.Plos One|March 29, 2013
Rational design of a fibroblast growth factor 21-based clinical candidate, LY2405319Alexei Kharitonenkov, John M Beals, Radmila Micanovic, et al.The Journal of Biological Chemistry|January 16, 2002
A potent synthetic LXR agonist is more effective than cholesterol loading at inducing ABCA1 mRNA and stimulating cholesterol effluxCarl P Sparrow, Joanne Baffic, My-Hanh Lam, et al.Endocrinology|June 20, 2002
A novel liver X receptor agonist establishes species differences in the regulation of cholesterol 7alpha-hydroxylase (CYP7a)John G Menke, Karen L Macnaul, Nancy S Hayes, et al.FEBS Letters|May 20, 2000
Activation of PPARdelta alters lipid metabolism in db/db miceM D Leibowitz, C Fiévet, N Hennuyer, et al.The Plant Journal : for Cell and Molecular Biology|March 5, 2015
SnRK1 from Arabidopsis thaliana is an atypical AMPKShane Emanuelle, Mohammed Iqbal Hossain, Isabel E Moller, et al.Bioorganic & Medicinal Chemistry Letters|May 6, 2003
5-Aryl thiazolidine-2,4-diones as selective PPARgamma agonistsHiroo Koyama, Julia K Boueres, Wei Han, et al.Science (New York, N.Y.)|May 13, 1999
Discovery of a small molecule insulin mimetic with antidiabetic activity in miceB Zhang, G Salituro, D Szalkowski, et al.Journal of Medicinal Chemistry|August 19, 2005
Novel 2,3-dihydrobenzofuran-2-carboxylic acids: highly potent and subtype-selective PPARalpha agonists with potent hypolipidemic activityGuo Q Shi, James F Dropinski, Yong Zhang, et al.Pageof 18